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Available online 12 October 2008The thymus contributes naïve, self MHC reactive, self tolerant T cells to the peripheral immune
system throughout life, albeit with a log-linear decline with age. Quantiﬁcation of thymic
function is clinically relevant in the setting of lymphoablation, but a phenotypic marker
distinguishing recent thymic emigrants from long lived naïve T cells remains elusive. T cell
receptor excision circles (TREC) are present in thymocytes exiting the thymus and
quantiﬁcation of the most frequent of these, the δrec-ψJα rearrangement has been widely
used as a measure of recent thymic function. However, interpretation of results presented as
TREC per cell has been criticised on the basis that extra-thymic cellular proliferation impacts
on peripherally determined TREC numbers. TREC/ml is now considered to be more
representative of thymic function than TREC/cell, especially where signiﬁcant cellular
proliferation occurs (e.g. during reconstitution following stem cell transplantation). Here we
describe the validation of a novel variation to the established assay, directly quantifying TREC/
ml from 300 µl whole blood. We show the assay to be reproducible, robust and stable
longitudinally and we show equivalence of performance when compared with more standard
assays. This assay particularly lends itself to the measurement of thymic function in children
and where monitoring clinical variables is limited by tissue availability.
© 2008 Elsevier B.V. Open access under CC BY-NC-ND license. Keywords:
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Paediatric1. Introduction
An important feature of the adaptive immune response
is the broad repertoire of T cell receptor (TCR) speciﬁcities
(Le Douarin et al., 1996). TCR diversity is generated through
rearrangements of TCR alpha (TCRα) chain and TCR beta
(TCRβ) chain genes, and subsequent random pairing of α
and β chain polypeptides (Arstila et al., 1999; Schlissel,
2003; Petrie et al., 1995). The TCR delta (TCRδ) chain locus
lies within the TCRα chain locus and its excision forms thellowship (AR Lorenzi)
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Y-NC-ND license. ﬁrst step in TCRα chain gene rearrangement (de Villartay
et al., 1988). One particularly frequent rearrangement occurs
between the δrec and ψJalpha element recombination
sequences. The intervening excised DNA is circularised by
the formation of a ‘signal joint’ forming a DNA episome,
termed a signal joint T cell receptor excision circle (sjTREC).
Approximately 70% of T cells emerging from the thymus
contain one or two sjTRECs (depending on whether one or
both TCRα loci genes are rearranged) (Verschuren et al.,
1997). As these T cells mature and proliferate their sjTRECs,
which are stable (Livak and Schatz, 1996) and do not divide,
are distributed amongst their progeny (Takeshita et al.,
1989).
In humans there is no speciﬁc phenotypic marker for
recent thymic emigrants. Although thymic imaging can
provide information about thymic capacity (Mackall et al.,
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and does not provide speciﬁc functional information. In 1998
Douek et al. (1998) published data suggesting that the
absolute number of TREC molecules measured per micro-
gram (μg) of DNA derived from isolated CD4+ and CD8+ T cells
represented a valid biomarker of thymic function. The
original semi-quantitative hybridisation assay has since
been superseded by assays that use real time quantitative
PCR for absolute TREC quantiﬁcation but the underlying
principle is that the proportion of peripheral blood T cells
containing a TREC provides an approximation of recent
thymic function.
TREC measurements have been presented in a number of
different ways. In some methods a TREC standard enables
the reporting of the absolute number of TREC molecules per
unit number of cells or TREC molecules per μg of DNAwithin
PBMC or T-lymphocytes (Nobile et al., 2004; Hug et al., 2003;
Zhang et al., 1999). In an alternative approach, TREC DNA has
been reported relative to genomic DNA within a particular
cellular subset (PBMC, T-lymphocytes, naïve T-lymhocytes)
(Ponchel et al., 2003) and yet others have sorted individual
T cell subsets and measured TREC within that subset
(Hazenberg et al., 2000). The different methods and units
used to measure TRECs affect the interpretation and
comparison of TREC data. Additionally, T cell proliferation,
T cell death and intra-cellular TREC degradation inﬂuence
the different assays in distinct ways. In particular, any assay
that uses a cellular subset as denominator, whether absolute
cell number or DNA content, will be inﬂuenced by cell
proliferation within that subset as illustrated by Hazenberg
et al. (2000). For instance if an assay reports TREC per cell, an
increase in circulating T- lymphocytes as a consequence of
peripheral division will artiﬁcially dilute the assay readout
regardless of recent thymic function. As thymic involution
occurs a proportional decline in peripheral blood TREC
numbers occurs and a coincident increase in naïve T cell
proliferation maintains the size of this T cell compartment
(Murray et al., 2003; Douek et al., 2001). Memory T cells
(CD45RO+) contain few if any detectable TREC (Kimmig et al.,
2002). Numerous mathematical models have been described
which attempt, using the available clinical data, to enhance
the interpretation of TREC data in the face of these con-
founding parameters (Hazenberg et al., 2000; Lewin et al.,
2002; Ye and Kirschner, 2002). Recently, several authors
have concluded that measuring TREC per millilitre of blood
overcomes the problem induced by cellular proliferation in
this assay, since the absolute number of TREC molecules,
assuming there is not signiﬁcant speciﬁc death of TREC
containing T cells, remains independent of total cell number
(Krenger et al., 2004; Ribeiro and Perelson, 2007).
In the current study we describe and evaluate a method
which directly quantiﬁes TREC from whole blood, using a
modiﬁcation of the currently well described real time PCR
assay. The value generated is TREC/ml and is therefore
measured without reference to cellular populations, remov-
ing any confounding attributable to cell proliferation. More-
over, it is performed using very small quantities of whole
blood (300 µl or less) and removes the necessity for
separating PBMC and other T cell subsets. The assay is
validated and has been tested in a large sample of healthy
control children and adults.2. Materials and methods
2.1. Samples
Ethical approval for the studywas givenby theNewcastle &
North Tyneside Research Ethics Committee. 9 ml blood
samples were obtained from healthy laboratory controls,
individuals attending local blood transfusion donation ses-
sions and from healthy children attending the local hospital
for simple surgical procedures such as hernia repair, circumci-
sion and correction of strabismus. All samples were collected
in to Vacuette EDTA K3 tubes (Greiner Bio-one, Austria) with
informed consent from the individual or a parent or guardian.
2.2. DNA extraction
DNA was extracted from 300 µl of whole blood using the
Wizard Genomic DNA extraction kit® (Promega) according to
the manufacturer's instructions and stored at 4 °C until use.
Sample purity and quantity was determined by spectro-
photometry (Nanodrop® ND-100).
2.3. Isolation of PBMC and CD4+ T cells
PBMC were isolated according to a standard, sucrose
density gradient (Lymphoprep®) protocol. CD4+ T cells were
isolated from PBMC with CD4+ positive selection beads
(MACS®—Miltenyi Biotec) using a semi-automated positive
selection protocol according to the manufacturers instruc-
tions yielding CD3+CD4+ T cells with 95–98% purity.
2.4. Real time quantitative PCR
The TREC content of each sample was determined by
quantitative real time PCR (RQ-PCR) using a standard curve
derived from plasmid constructs encoding the sjTREC
sequence (Douek et al., 2000). Standards were diluted over
the range 107–101 and a curve was run in each experiment
together with standard samples, positive and negative
controls. RQ-PCR was performed using an ABI Prism 7900HT
Sequence Detector System and data analysed using SDS2.2
software from the manufacturer (Applied Biosystems, War-
rington, UK). Taqman™ Hydrolysis technology was used in a
25 μl reaction mixture containing 700 nM of each primer
CACATCCCTTTCAACCATGCT and GCCAGCTGCAGGGTTTAGG,
150 nM Taqman hydrolysis probe (6-FAM-ACACCTCTGGT-
TTTTGTAAAGGTGCCCACT-TAMRA) and 12.5 µl JumpStart™
Taq ReadyMix (SIGMA). Each reaction contained 200 μg DNA.
Thermal cycling conditionswere 50 °C for 2min then 95 °C for
10 min then 95 °C for 15 s and 60 °C for 1 min for 40 cycles.
Experimental samples were run in duplicate and the replicate
average value taken as the sample result. Primers and probes
were all from SIGMA-Aldrich.
2.5. Statistics
All statistical analysis was performed using SPSS© 11th
edition software. Values for TREC/ml were log transformed as
described in the text prior to statistical analysis. Population
distributions were tested with a one sample Kolmogorov–
Smirnov test to conﬁrm normality. Correlations for normally
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correlation coefﬁcient unless otherwise stated. Analysis of
covariance (ANCOVA) was used to test for differences
between groups where other covariates were present. Results
were considered signiﬁcant when pb0.05.
3. Results
3.1. Direct quantiﬁcation of TREC per millilitre of whole blood
We devised a mathematical description for the determi-
nation of TREC per millilitre of whole blood, where DNA was
extracted from a 300 μl aliquot of the sample. TREC permlwas
derived using Eq.(1).
Total DNA μgð Þ in 300 μl WBð Þ
DNA μgð Þ amplified in RQ−PCRð Þ
 
 No: of TRECð Þ  1000
300
 
ð1Þ
Eq. (1)—Calculation of TREC per ml of whole blood (WB—
whole blood; RQ-PCR—real time quantitative PCR, No. of TREC
is absolute value derived from RQ-PCR standard curve).
Calculated vales for TREC/ml were log transformed since
the size of the error in individual results (which had a range of
1.5Log10) was proportional to the size of the mean (Bland,
2000). This also allowed statistical analysis to be performed
on normally distributed data.
From Eq. (1), four sources of experimental variability were
identiﬁed that could contribute to measurement error in theFig. 1. Determination of assay reproducibility. DNA was extracted from ten 300 µl re
then calculated for ﬁve of these replicates in three donors (B). To examine the po
replicates of a single sample at 1 h, 6 h and 24 h (C). WBLogTREC/ml was then quantiﬁassay. Such methodological considerations are true for most
systems of this nature but infrequently described in the
literature. We therefore sought to conﬁrm that we could a)
reproducibly extract the same quantity of DNA from a single
donor sample on multiple occasions; b) that we could
reproducibly quantify TREC molecules from single donor
samples on multiple occasions; c) that there was no effect of
time from sample donation to sample preparation on values
obtained and d) that TREC values were independent of total
white cell count—since granulocytes, B cells and NK cells are
all nucleated cells present inwhole blood. Fig. 1(A) shows that
DNA was reproducibly extracted from whole blood samples
and Fig. 1(B) that TREC/ml was reproducibly calculated in
three of six of these samples. Over a 24 h period there was no
effect of time from the sample being drawn to being
processed on the quantity of DNA extracted—Fig. 1(C) or the
determined TREC value for that sample—Fig. 1(D). The
coefﬁcient of variation for the DNA extraction was calculated
to be 5.07% from six samples extracted 10 times each.
All white cells (granulocytes, monocytes, B cells, NK cells
and T cells) in whole blood are nucleated and thus in this
assay contribute to the total DNA extracted from any sample.
Since the number of white cells (WC) varies between
individuals the total WC count may alter the sensitivity of
TREC measurements. We therefore assessed the relationships
between total WC count, lymphocyte count, neutrophil count
and WBLogTREC/ml. WC count and subset counts were
determined in a clinical laboratory for a small sample of
healthy controls. Samples from patients with rheumatological
autoimmune diseases who had blood counts available wereplicate aliquots of whole blood from six healthy donors (A). WBTREC/ml was
tential effect of a delay in sample processing, DNA was extracted from ﬁve
ed in all ﬁve aliquots for each time point (D). All plotted values aremean±SD.
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cantly correlated with lymphocyte count (sum of T cells (60–
80%), B cells (12–20%), NK cells (10–15%)) (r=0.71; pb0.01).
WC count was correlated to a lesser extent, reﬂecting the
lymphocyte content of total WC (approximately one third
lymphocytes), (r=0.38; pb0.05). Neutrophil count was not
correlated with WBLogTREC/ml—Fig. 2.
3.2. Determining assay precision
The precision of any assay to detect the presence or
absence of a quantiﬁable unit is reduced as the limit of
detection for the assay is approached. Here, as the number of
TREC molecules detected per reaction approaches one, theFig. 2. WBLogTREC/ml is positively correlated with lymphocyte count (A) (Pearson
(r=0.38; pb0.05) (B) but not neutrophil count (p=n.s.) (C) when directly quantiﬁedprecision of the assay declines, reﬂecting the limit of
detection of real time PCR (Ginzinger, 2002). To assess this
experimentally we quantiﬁed TREC from 175 individual
samples in duplicate. The overall correlation coefﬁcient for
the comparison was 0.96; (pb0.01). However, as the number
of TREC quantiﬁed per sample fell below 10, variation in the
ﬁnal result was increased. Fig. 3 shows that values to the left
of the dashed line (which represents the values of WBLog-
TREC/ml given by samples in which ‘10 or less TREC’ were
quantiﬁed in the real time PCR) are more widely dispersed
from the regression line than values to the right which
represent samples inwhich ‘11 ormore TREC’weremeasured.
The coefﬁcient of variation for the real time reaction was
calculated by running two standard samples of DNA in 25's correlation coefﬁcient r=0.67; pb0.01) and weakly with white cell coun
from whole blood.t
Fig. 3. Duplicate estimation of the number of TRECmolecules per samplewasperformed for 175 individuals. Each data point represents the average value obtained from
two simultaneous PCRs performed on two (i and ii) occasions for a single donor. Overall, the assay was shown to be highly reproducible as evidenced by the regression
line's closeness to the diagonal and Pearson's correlation coefﬁcient r=0.96 (pb0.01). However, as the number of TREC determined per reaction approached 10, the
reproducibility of the assaywas less. Thevertical dashed line represents the averageﬁnal valueofWBLogTREC/ml, calculatedaccording to Eq. (1), for samples inwhich10
TREC were measured. Values to the left of the line thus represent samples with less than 10 TREC and those to the right those with more than 10 TREC.
Fig. 4. (A) Comparison of TREC values derived from WB DNA (ﬁlled bars), PBMC DNA (striped bars) and CD4+ T cell DNA (white bars) in blood drawn from ten
patients with rheumatoid arthritis. The age (yrs) of the patients is given below each. TREC values are those derived from the assay standard curve to give raw data
values for comparison. Where there are no bars for individual subsets TREC were not detected in the PCR reaction (or insufﬁcient DNA extracted in the case of the
two samples where CD4+ samples were tested). Each reactionwas performed using 200 ng of DNA. (B) TREC values derived from the PCR reactions were compared
in these ten patients plus a further six patients from DNA extracted from PBMC and WB DNA. The values derived are strongly correlated (r=0.92; pb0.01).
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Fig. 5. Biological variation inWBLogTREC/ml in HC over 3months. Nine individuals had blood drawn onmore than two occasions over a three month period. On each occasion DNAwas extracted and stored. TREC values were
determined for each individual in a single real time experiment. Age and gender for each individual is given. The average value for each individual was taken and plotted against age to check that the group was a
representative one (Pearson's r for the correlation with age=−0.904; pb0.01). The standard deviation about the mean for each individual was independent of age (data not shown).
190
A
.R.Lorenzi
et
al./
Journal
of
Im
m
unological
M
ethods
389
(2008)
185
–194
Fig. 6. Healthy control samples were divided into 5 year groupings and
WBLogTREC/ml determined. The mean (thick bar), inter-quartile range
(boxes) and 95% conﬁdence intervals (whiskers) are plotted. Outliers are
plotted as stars (⁎). Age was negatively correlated with WBLogTREC/ml
(Pearson's r=−0.86; pb0.01).
Table 1
Mean WBLogTREC/ml for ﬁve year cohorts of healthy controls (male and
female combined) with descriptive statistics for each cohort
Age groups n Minimum Maximum Mean Standard deviation
0–5 32 4.79 5.79 5.26 0.26
5.1–10 33 4.56 5.72 5.05 0.26
10.1–15 15 4.50 5.4 5 0.28
15.1–20 4 4.38 4.88 4.64 0.20
20.1–25 14 4.23 4.83 4.53 0.19
25.1–30 9 4.21 4.79 4.55 0.20
30.1–35 20 3.90 5.12 4.45 0.26
35.1–40 16 2.58 4.9 4.12 0.56
40.1–45 9 3.28 4.74 4.16 0.46
45.1–50 16 3.53 4.69 4.05 0.30
50.1–55 23 3.29 4.36 3.84 0.26
55.1–60 15 2.75 4.69 3.68 0.50
60.1–65 10 2.80 4.03 3.48 0.40
65.1–70 4 3.36 4.34 3.84 0.43
Data corresponds to values presented in Fig. 5.
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standard sample respectively (data not shown). Thus, the overall
experimental coefﬁcient of variation from DNA extraction to
TREC determination (variation in DNA extraction multiplied by
variation in RQ-PCR of TREC) was 8.7%, range 7.6–9.8%.
3.3. Comparison of TREC determination from WB derived DNA
with that from PBMC and CD4+ derived DNA
For a given quantity of total DNA analysed, selection of
TREC-rich cells increases the probability of detecting a TREC
in a PCR. Thus, in 200 ng DNA derived from selected T cells the
absolute number of TREC will be higher than in 200 ng DNA
from PBMC which in turn will be higher than in 200 ng DNA
from WB. We have shown that our assay becomes less
reproducible as TREC/reaction approaches 10 (Fig. 3). How-
ever, whereas the use of WB as a template for TREC
measurement may reduce assay sensitivity, variable T cell
recovery may alter the accuracy of analyses requiring cellular
isolation. We therefore quantiﬁed TREC from DNA derived
from each type of sample in patients known to have values
around the limit of detection—elderly patients with rheuma-
toid arthritis taking disease modifying anti-rheumatic drugs
(DMARDs) (Ponchel et al., 2002).
Samples were initially drawn from ten patients (mean age
60.5 yrs (range 48–74 years)) and TREC quantiﬁed for each
usingWB, isolated PBMC and CD4+ Tcells. Fig. 4(A) shows that
TREC were detected in 8 patients using CD4+ T cell DNA, 6
patients using PBMC DNA and 5 patients using WB DNA. As
the frequency of TREC per sample increased (as judged by the
TREC content of CD4+ T cells) the likelihood of detecting TREC
using both of the other sample types increased, conﬁrming
the sensitivity advantage of selecting a TREC-rich subset.
However it is notable that in two patients where insufﬁcientCD4+ Tcells were recovered, TRECwere detected in both using
WB DNA and from one using PBMC DNA, emphasising the
potential cost of cell isolation in terms of accuracy. The
detection of TREC in WB DNA but not in PBMC DNA from the
same individual may also reﬂect stochastic factors as the limit
of assay sensitivity is approached.
We then compared TREC values obtained from PBMC and
WB DNA to conﬁrm that results from both assays were
consistent. We did not compare either with CD4+ T cell DNA
since the former two assays will additionally include TREC
present in CD8+ T cells. To increase the sample size for this
analysis we isolated DNA from a further 6 RA patients. TREC
were detected in 10/16 using WB and 11/16 using PBMC DNA.
The correlation coefﬁcient betweenWB TREC and PBMC TREC
values was very strong (r=0.92; rb0.01) conﬁrming equiva-
lence of the data (Fig. 4B).
3.4. Whole blood TREC per millilitre (WBLogTREC/ml) values are
biologically stable over time in healthy individuals
Despite a decline of approximately 1.5 logs over the age
span tested, TREC values at any one age in normal healthy
individuals are still highly variable (Zhang et al., 1999). We
therefore sought to examine whether biological variation
within an individual over time might contribute to this
variation. Nine healthy male and female volunteers aged
between 22 and 60 had their WBTREC/ml quantiﬁed serially
over a three month period. We found that WBLogTREC/ml
remained stable over this period (Fig. 5). Using the standard
deviation about the mean as a summary measure (as
described by Matthews et al., 1990) we showed that there
was no biological variation above that which could be
expected from the known inter-assay variation (p=0.45),
conﬁrming that any biological variation in healthy individuals
occurs at a level not detectable by this assay.
3.5. WBLogTREC/ml declines with age and varies with gender in
healthy individuals
In healthy individuals thymic function is dependent on
age. In a cohort of 221 healthy controls ranging in age from
new born (cord blood) to 69 we conﬁrmed a decline in the
Fig. 7. Gender differences are detectable in WBLogTREC/ml when females (open circles/ dashed regression line) are compared with males (closed circles—solid
regression line) at any age. There is a statistically signiﬁcant difference between the two groups after correcting for age (p=0.043). The negative correlationwith age
is maintained in each population. (A single sample (male; TREC/ml—2.58) was removed from this analysis because it was an outlier exerting signiﬁcant inﬂuence on
the result when included).
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et al. (1999) found, there is a suggestion of an accelerated
decline in thymic function at puberty but it was not possible
to conﬁrm this observation because our sample number in
this age range was small (n=4 for 15–20 years) (Fig. 6 and
Table 1). Moreover, samples at this age were all from males. It
has previously been shown that males have reduced thymic
function compared to age-matched females (Pido-Lopez et al.,
2001). Using the whole blood TREC assay we have conﬁrmed
this difference and demonstrated that it extends back into
childhood (Fig. 7). The overall age-adjusted mean WBLog-
TREC/ml for males (n=113) is 4.378 and for females (n=106) is
4.573 (p=0.043). Zhang et al. (1999) did not analyse their data
on the basis of gender so comparisons cannot be made.
4. Discussion
We present here a novel modiﬁcation to the well
established and widely used method of measuring thymic
function – the ‘TREC Assay’ (Douek et al., 1998) – which
quantiﬁes TREC per ml directly from very small volumes of
peripheral whole blood. As discussed earlier, we and others
have concluded that TREC/ml provides a better estimate of the
thymic contribution to the peripheral T cell compartment in
cross-sectional analyses than TREC per cell, the interpretation
of which is complicated by the effects of peripheral cellular
division. Whereas under steady state conditions TREC/ml and
TRECper 106 PBMC (a frequently used unit of TRECper cell) are
likely to give comparable results, this is not truewhere there is
signiﬁcant and rapid T cell turnover as, for example, in HIV/
AIDS after highly active anti-retroviral therapy or following
HSCT for haematological malignancy or autoimmune disease
(Ye and Kirschner, 2002). Such clinical situations are, however,
of considerable clinical interest.
The thymus is crucial to reconstitution of the T cell
compartment following lymphodepletion and also in estab-
lishing a normal, diverse T cell repertoire capable of mounting
an adaptive immune response to neo-antigens, inhibiting
auto-reactive processes (by the generation of thymus derivedregulatory T cells) and detecting early malignant expansions
(Dumont-Girard et al., 1998). Of note, recent evidence
suggests that early lymphocyte reconstitution following
allogeneic or autologous stem cell transplant (SCT) for
haematological malignancy is positively correlated with a
better clinical outcome and decreased risk of relapse (Joao
et al., 2006; Parkman et al., 2006; Svaldi et al., 2003). It is
known that adults reconstitute poorly in comparison with
children, that impaired reconstitution is correlated with risk
of life threatening infection post transplant (Small et al.,
1999), and that this is due to age related thymic involution
(Fallen et al., 2003). Therefore, investigators are now devel-
oping strategies which aim to restore thymic function and
reverse thymic involution in adults (van den Brink et al.,
2004) and thymic adjuvants such as Keratinocyte Growth
Factor, IL-7, Lupron (chemical sex-steroid ablative agent) and
in vitro expanded T/NK precursor cells are currently being
evaluated in early clinical trials (for recent reviews see
Goldberg et al., 2007; Legrand et al., 2007). The impact of
these agents on thymic functionwill therefore be evaluated in
larger clinical studies in the near future.
We have devised and validated a ‘whole blood TREC assay’
using a large group of healthy male and female individuals
over a seven decade age range for use in both cross-sectional
and longitudinal studies. Using this assay we have conﬁrmed
the described 1.5Log fold decline in TREC values with normal
aging (Zhang et al., 1999) and the small, previously described,
increase in thymic function in females when compared with
age-matched males (Pido-Lopez et al., 2001). We have shown
that, in individual adults, thymic function is stable in the short
to medium term, irrespective of age, thus demonstrating that
this assay can be used to monitor thymic function long-
itudinally and, furthermore, that cross-sectional analyses can
be considered representative of recent thymic function, at
least in healthy individuals. The assay is cheap, reproducible,
stable over time and robust to use in longitudinal studies. Our
modiﬁcation to the established TREC assay allows thymic
function to be measured rapidly from very small volumes of
blood and thus particularly lends itself to use in clinical
193A.R. Lorenzi et al. / Journal of Immunological Methods 389 (2008) 185–194settings where limited tissue is available, for example in
paediatric studies, and/or where longitudinal information is
required. The lower limit of detection of our assay is higher
than that for assays quantifying TREC using selected T cell
subsets but is directly comparable with assays using PBMC
derived DNA, with the advantage of signiﬁcantly lower tissue
volume requirement and sample processing time. When
working at the limit of assay sensitivity the probability of
TREC detection could be increased by quantifying TREC from
replicate aliquots of individual samples and adjusting the
derived values accordingly.
Our assay cannot distinguish between CD4+ and CD8+
contributions to the recent thymic emigrant subset. However,
this limitation is common to most thymic function measure-
ments. Sorting peripheral T cell subsets and quantifying TREC
within them allows both maturation pathways of recent
thymic emigrants to be explored (as we have previously
shown Ponchel et al., 2002) and, where the total T cell count is
known, TREC/ml to be calculated. However, this requires large
volumes of blood and is less acceptable to patients and
treating physicians when there are numerous other clinical
and experimental requirements for peripheral blood. Reﬂect-
ing this problem, several clinical studies have moved to
quantify recent thymic emigrants using the phenotype
CD45RA+CD31+. Whilst this subset is certainly TREC-rich
(Kimmig et al., 2002; Junge et al., 2007) it does not always
correlate strongly with TREC values and may be capable of
self-renewal in the absence of thymic output quantiﬁed by
TREC/ml (Kilpatrick et al., 2008; Lorenzi et al., 2008).
Eyrich et al. have recently employed a novel approach to
the measurement of thymic function in the post-SCT context.
They showed that two speciﬁc time points post transplant
were of particular clinical interest—Tmin (days until ﬁrst
detectable TREC) and Tplateau (days until stable TREC values).
These two time points were independently regulated by age
and grafted stem cell number respectively (Eyrich et al.,
2005). The effects of differing conditioning regimes, graft T
cell depletion, use of ex vivo thymocyte precursor expansion
protocols and thymic adjuvants are all currently being
investigated in clinical trials to determine their impact on
thymic output. Our assay will provide a useful clinical tool for
the study of these strategies by allowing, for example, Tmin
and Tplateau to be readily quantiﬁed from small clinical
samples in large clinical cohorts. Time to detection of ﬁrst
TRECmay be delayed using our assay in such a setting but this
disadvantage should be outweighed by the signiﬁcantly
reduced sample volume and manipulation required to
conduct the assay—a consideration of particular relevance in
a paediatric context. Since early reconstitution appears to be
associated with better prognosis following HSCT in haema-
tological malignancy, our assay could also be validated as a
prognostic marker.
In summary, our group has previously validated and
published an assay that is designed speciﬁcally for the
determination of TREC per cell (Ponchel et al., 2003). We
now present an assay that directly quantiﬁes TREC/ml from
whole blood. The combination of the two assays, alongside
appropriate cell surface labelling contributes a set of tools
with which thymic reconstitution can be investigated
following lymphoablative treatments and in the clinical
evaluation of thymic adjuvant therapies.Acknowledgement
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